Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Active Biotech AB ( (SE:ACTI) ) has shared an update.
Active Biotech AB has announced an Extraordinary General Meeting to discuss significant changes, including amendments to the Articles of Association and a new share issue. The proposed changes aim to increase the company’s share capital and authorize the Board to issue new shares, potentially impacting the company’s financial structure and attracting new investors.
More about Active Biotech AB
Active Biotech AB is a biotechnology company based in Lund, Sweden, focusing on the development of pharmaceuticals for the treatment of autoimmune diseases and cancer.
YTD Price Performance: 44.44%
Average Trading Volume: 4,892,505
Technical Sentiment Signal: Sell
Current Market Cap: SEK192.6M
See more data about ACTI stock on TipRanks’ Stock Analysis page.